These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1322645)

  • 1. Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages.
    Perno CF; Yarchoan R; Balzarini J; Bergamini A; Milanese G; Pauwels R; De Clercq E; Rocchi G; Calio R
    Antiviral Res; 1992 Apr; 17(4):289-304. PubMed ID: 1322645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.
    Perno CF; Cooney DA; Gao WY; Hao Z; Johns DG; Foli A; Hartman NR; Caliò R; Broder S; Yarchoan R
    Blood; 1992 Aug; 80(4):995-1003. PubMed ID: 1379854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
    J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of anti-HIV agents to inhibit HIV replication in monocyte/macrophages or U937 monocytoid cells under conditions of enhancement by GM-CSF or anti-HIV antibody.
    Perno CF; Cooney DA; Currens MJ; Rocchi G; Johns DG; Broder S; Yarchoan R
    AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1051-5. PubMed ID: 2223241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.
    Perno CF; Balestra E; Aquaro S; Panti S; Cenci A; Lazzarino G; Tavazzi B; Di Pierro D; Balzarini J; Calio R
    Mol Pharmacol; 1996 Aug; 50(2):359-66. PubMed ID: 8700144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication.
    Foli A; Saville MW; Baseler MW; Yarchoan R
    Blood; 1995 Apr; 85(8):2114-23. PubMed ID: 7718882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes.
    Bergamini A; Perno CF; Balzarini J; Capozzi M; Marinelli L; Milanese G; Pesce CD; Calió R; Rocchi G
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1239-47. PubMed ID: 1381599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy of human immunodeficiency virus-related disease.
    Mitsuya H; Yarchoan R; Kageyama S; Broder S
    FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
    Pauwels R; Andries K; Desmyter J; Schols D; Kukla MJ; Breslin HJ; Raeymaeckers A; Van Gelder J; Woestenborghs R; Heykants J
    Nature; 1990 Feb; 343(6257):470-4. PubMed ID: 1689015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes.
    Aquaro S; Perno CF; Balestra E; Balzarini J; Cenci A; Francesconi M; Panti S; Serra F; Villani N; Caliò R
    J Leukoc Biol; 1997 Jul; 62(1):138-43. PubMed ID: 9226005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages.
    Hammer SM; Gillis JM; Pinkston P; Rose RM
    Blood; 1990 Mar; 75(6):1215-9. PubMed ID: 2178702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection.
    Bridges CG; Taylor DL; Ahmed PS; Brennan TM; Hornsperger JM; Navé JF; Casara P; Tyms AS
    Antimicrob Agents Chemother; 1996 May; 40(5):1072-7. PubMed ID: 8723443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the combination effect of different antiviral compounds against HIV in vitro.
    Sørensen AM; Nielsen C; Mathiesen LR; Nielsen JO; Hansen JE
    Scand J Infect Dis; 1993; 25(3):365-71. PubMed ID: 7689746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs.
    Pauwels R; Andries K; Debyser Z; Kukla MJ; Schols D; Breslin HJ; Woestenborghs R; Desmyter J; Janssen MA; De Clercq E
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2863-70. PubMed ID: 7535037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages.
    Szebeni J; Wahl SM; Popovic M; Wahl LM; Gartner S; Fine RL; Skaleric U; Friedmann RM; Weinstein JN
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3842-6. PubMed ID: 2542948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents.
    Buckheit RW; Germany-Decker J; Hollingshead MG; Allen LB; Shannon WM; Janssen PA; Chirigos MA
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1097-106. PubMed ID: 7508723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol.
    Heredia A; Davis C; Redfield R
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):246-55. PubMed ID: 11115955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agents for treating human immunodeficiency virus infection.
    Acosta EP; Fletcher CV
    Am J Hosp Pharm; 1994 Sep; 51(18):2251-67; quiz 2286-7. PubMed ID: 7801986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.